Dendreon Data To Be Released Tomorrow at 9AM EST!
April 13, 2009 at 6:26 pm EST | Tags: Clinical Trials
Tomorrow is the day everyone has been waiting
for – patients, doctors, investors and the entire world of biotech! Dendreon will be hosting a conference call tomorrow, Tuesday, April
14, 2009, at 9:00 AM ET (6:00 AM PT) to review the outcome of the
FINAL analysis of its IMPACT (IMmunotherapy for Prostate
AdenoCarcinoma Treatment, also known as D9902B) clinical trial of
PROVENGE (sipuleucel-T), the company’s investigational active cellular
immunotherapy for the treatment of advanced prostate cancer.
The stock has seen serious activity lately, mostly from the company’s reservation of conference space to present Provenge data at the annual American Urological Association meeting on April 28th.
For more on Dendreon, take a look at Xconomy’s piece a few weeks ago.
Fortunes will be made or lost tomorrow, depending on positions…stay tuned!
Image from cnbc
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
